However, a mechanistic basis for this activity is difficult to explain, since EGFR activation is not commonly seen in colon cancers, and the clinical activities of EGFR-targeted therapies shows no correlation with EGFR expression (Chung et al, 2005). This evidence concerns the gene EGFR and malignant colon neoplasm.